Huadong Medicine (000963.SZ): Products and Partnered Products Included in National Medical Insurance Catalog and Commercial Insurance Innovative Drug Catalog

Stock News
2 hours ago

Huadong Medicine Co.,Ltd. (000963.SZ) has announced that certain of its products and partnered products have been included in the new version of the drug catalog and the new version of the commercial insurance innovative drug catalog.

Mefatinib Maleate Tablets, produced by the company's wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., has been included in the negotiated drug section during the agreement period.

The partnered product Prusogliptin Tablets has completed its renewal, with the payment standard and payment scope remaining unchanged. Tacrolimus Granules has been adjusted to routine catalog management, with the payment scope remaining the same as the previous version of the drug catalog. The partnered product Zevor-cel Injection continues to be included in the new version of the commercial insurance innovative drug catalog.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10